Skip to main content

InVitro International

corporate_fare Company Profile

InVitro International

IVRO·OTC·Life Sciences·CIK 0001341401

InVitro International develops test kits for non-animal testing applications in the United States and internationally. The company's product portfolio includes the Irritection Assay System, an in vitro test that predicts the ocular and dermal irritancy of chemicals, mixtures, and product formulations by observing changes in relevant macromolecules. Another key product is Corrositex, a non-animal test designed to determine skin corrosivity using a biomembrane and chemical detection systems. Beyond test kits, InVitro International offers customized technology services, specifically for the installation and testing processes of the Irritection Assay System. The company also provides independent testing laboratory services for irritancy and corrosivity testing requirements, alongside consultation and assistance services. InVitro International's products are primarily utilized across various industries, including cosmetics, personal care, household products, textiles, pharmaceuticals, chemicals, hazardous waste, and transportation. Incorporated in 1985, InVitro International is headquartered in Placentia, California.

InVitro International (OTC:IVRO) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 1 item for IVRO at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-08-11, rated 7/10.

Recent high-impact activity:

  • InVitro International Q3 Sales Plunge 24%, Net Income Drops 82%

Short Interest & Short Volume

13.74 days to cover

FINRA reported short interest of 5,000 shares in IVRO as of the October 30, 2026 settlement, unchanged from the prior period — about 13.7 days to cover at its recent average daily volume. On November 20, 2026, 42.9% of IVRO volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)5,000 shares as of October 30, 2026
Change vs prior period 0.0%
Days to cover13.74 at avg daily volume of 364
Daily short volume (FINRA facilities)42.9% of 70,000 shares on November 20, 2026

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

$0.084 +20.00% today
52-week range · as of 2026-08-11 $0.025 – $0.16
Market cap
$1.86M
Volume
70K (2.0× avg)
3-mo avg 34.9K
Live data · 2026-11-21 22:20 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed IVRO - Latest Insights

IVRO
Aug 11, 2026, 9:00 AM EDT
Source: TMX Newsfile
Importance Score:
7
Price at Filing: $0.0679
Real-time Price: $0.084 info
Change: +$0.0161 (+24%) info
Market Cap: $1.861M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets